Japanese
Showing 26 - 50 of 4,176
Cholangiocarcinoma Non-resectable, Cholangiocarcinoma Metastatic Trial (Ivosidenib)
Not yet recruiting
- Cholangiocarcinoma Non-resectable
- Cholangiocarcinoma Metastatic
- (no location specified)
Oct 10, 2023
Healthy Trial in Cypress (LY3462817 (SC), Placebo (SC), LY3462817 (IV))
Recruiting
- Healthy
- LY3462817 (SC)
- +3 more
-
Cypress, CaliforniaAltasciences Clinical Los Angeles, Inc
Jul 7, 2022
Healthy Trial (Daridorexant 10 mg, Daridorexant 25 mg)
Not yet recruiting
- Healthy
- Daridorexant 10 mg
- Daridorexant 25 mg
- (no location specified)
Jun 1, 2023
Healthy Volunteers Trial in Anaheim (Danicamtiv, Placebo)
Not yet recruiting
- Healthy Volunteers
- Danicamtiv
- Placebo
-
Anaheim, CaliforniaAnaheim Clinical Trials
Mar 29, 2023
Herpes Simplex Trial in Tokyo (HSVTI Formulation 1, HSVTI Formulation 2, Placebo)
Not yet recruiting
- Herpes Simplex
- HSVTI Formulation 1
- +2 more
-
Tokyo, JapanGSK Investigational Site
Aug 4, 2023
Advanced Solid Tumors Trial in Chuo-ku (MEDI5752)
Active, not recruiting
- Advanced Solid Tumors
- MEDI5752
-
Chuo-ku, JapanResearch Site
Jan 19, 2023
Chronic Graft-versus-Host Disease (cGVHD) Trial in Randwick (AMG 592, Placebo)
Completed
- Chronic Graft-versus-Host Disease (cGVHD)
- AMG 592
- Placebo
-
Randwick, New South Wales, AustraliaResearch Site
May 23, 2023
Healthy Participants Trial in Neuss (NNC0113-6856, Placebo)
Not yet recruiting
- Healthy Participants
- NNC0113-6856
- Placebo
-
Neuss, GermanyNovo Nordisk Investigational Site
Sep 29, 2023
Contrast Enhancement in Magnetic Resonance Imaging, Healthy Volunteers Trial in Fukuoka (BAY1747846, Matching )
Completed
- Contrast Enhancement in Magnetic Resonance Imaging
- Healthy Volunteers
- BAY1747846
- Matching placebo
-
Fukuoka, JapanSOUSEIKAI Fukuoka Mirai Hospital
Nov 6, 2023
Pulmonary Arterial Hypertension Trial (Sotatercept)
Not yet recruiting
- Pulmonary Arterial Hypertension
- Sotatercept
- (no location specified)
Apr 5, 2023
Healthy Trial in Cypress (CD388 Injection, Saline )
Recruiting
- Healthy
- CD388 Injection
- Saline placebo
-
Cypress, CaliforniaAltasciences Clinical Los Angeles, Inc.
Jan 18, 2023
COVID-19, SARS-CoV-2 Trial in Fukuoka-shi (AZD3152 (Cohort 1), Placebo (Cohort 1), AZD3152 (Cohort 2))
Not yet recruiting
- COVID-19, SARS-CoV-2
- AZD3152 (Cohort 1)
- +5 more
-
Fukuoka-shi, JapanResearch Site
Jun 27, 2023
Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies Trial in Chuo-ku (ASP1948)
Completed
- Locally Advanced (Unresectable) or Metastatic Solid Tumor Malignancies
-
Chuo-ku, Tokyo, JapanSite JP810001
Jan 17, 2023
Squamous Cell Carcinoma Trial (MK-3475A)
Not yet recruiting
- Squamous Cell Carcinoma
- MK-3475A
- (no location specified)
Sep 11, 2023
Solid Tumors, KRAS Mutation Trial in Chiba, Kashiwa, Tokyo, Chuo-ku, Tokyo, Koto-ku (BI 3011441)
Completed
- Solid Tumors, KRAS Mutation
- BI 3011441
-
Chiba, Kashiwa, Japan
- +2 more
Nov 11, 2022
Japanese Participants With X-linked Retinitis Pigmentosa
Recruiting
- X-Linked Retinitis Pigmentosa
-
Tokyo, JapanNational Hospital Organization Tokyo Medical Center
Jan 3, 2023
Healthy Subjects (Indication: Asthma) Trial in Harrow (Elarekibep, Placebo)
Not yet recruiting
- Healthy Subjects (Indication: Asthma)
- Elarekibep
- Placebo
-
Harrow, United KingdomResearch Site
Mar 20, 2023
Learn About Venous Thromboembolism Treatment With Rivaroxaban in
Completed
- Treatment of Venous Thromboembolism
- Rivaroxaban (Xarelto, BAY59-7939)
-
Japan Databases, Japan
- +1 more
Jan 10, 2023